Jefferies analysts said in a Thursday note they view the results positively, especially a jump in surgeries and "healthy organic growth trends." Still, CHS' stock was trading down about 8% Thursday morning.
Original source: https://www.healthcaredive.com/news/chs-profit-down-in-q2-but-buoyed-by-non-covid-19-care/604096/